魏勇军，博士，郑州大学药学院副教授。2008年本科毕业于陕西师范大学生物学基地班；2014年博士毕业于中国科学院上海生命科学研究院；2014年-2016年，瑞典查尔莫斯理工大学博士后；2017-2018年就职于中国科学院上海生命科学研究院中科院合成生物学重点实验室；2018-至今就职于郑州大学。
研究方向：1、利用合成生物学方法，在微生物中高效合成中草药活性分子、食用蛋白、油脂等；2、解析人体和环境微生物组，个性化精准调控微生物菌群。
主持国自然面上、国际（地区）合作与交流项目、青年基金等3项国自然在内的10多项横向和纵向项目。已发表论文85篇，以一作/通讯（含共）在Trends in Biotechnology、Green Chemistry、Chemical Engineering Journal、《中国科学：生命科学》等期刊发表论文61篇，他引2000余次，H因子25。以第一主编出版2本Elsevier出版社合成生物学书籍，共同主编英文eBook 2本；参编中英文著作2部。指导国家级大学生创新创业训练项目等多项本科生科研项目。
目前，担任BMC Microbiology（IF：4.2）、Cell旗下Heliyon（IF：4）、BMC Biotechnology（IF：3.5）等5本国际SCI期刊编委。担任国产高水平英文期刊The Innovation（IF：32.1）、iMeta、Eco-Environment & Health的青年编委和Gene & Protein in Disease编委。担任Biomolecules（IF：5.5）、Frontiers in Microbiology（IF：5.2）、Frontiers in Molecular Biosciences（IF：5）等10多本国际期刊的审稿编委、专刊主编或客座副主编。
担任Nature Communication等40多家高水平SCI 杂志的审稿人。
已获批美国、德国、日本等11 项国际专利在内的23项授权专利；在审国内外专利16项。
担任国际应用微生物学会干净水科学咨询委员会委员（Applied Microbiology International, Clean Water Scientific Advisory Group Member）、河南省微生物学会理事，河南省感染病与生物安全专业委员会委员、河南省肿瘤精准诊断与治疗专业委员会委员。担任热心肠智库专家。担任多家生物技术公司研发科学家。
联系方式：yongjunwei@zzu.edu.cn
I am currently working as an Associate Professor at the School of Pharmaceutical Sciences and Laboratory of Synthetic Biology, Zhengzhou University, China. My research interests revolve around understanding the human microbiome and synthetic microbiology, with a focus on applying microbiota and synthetic biology in addressing human health issues.
I received my bachelor's degree from Shaanxi Normal University and Ph.D. degree from the Shanghai Institute for Plant Physiology and Ecology, Chinese Academy of Sciences (CAS) from 2010 to 2014. Following that, I worked as a post-doctoral researcher at Jens Nielsen’s lab at Chalmers University of Technology in Sweden from 2014 to 2016. In 2017, I served as an Assistant Professor at the Plant Physiology and Ecology department of the Chinese Academy of Sciences before joining Zhengzhou University in 2018.
To date, I have published more than 86 papers with over 2000 citations (Google Scholar h-index: 25). Some of these papers focus on human and environmental sustainability using microbiome and synthetic biology approaches. My primary research strategy entails the development of microbiome and metagenomic methods to gain insights into the diversity, novelty, and distribution of human microbiota and various environments. Additionally, I also work on producing bioactive natural products through engineered or synthetic microbes.
I currently serve as an editorial board member for BMC Microbiology, BMC Biotechnology, Journal of Applied Microbiology, and Letters in Applied Microbiology. Furthermore, I have organized 11 research topics for other journals and have reviewed numerous articles for over 45 different journals, including Nature Communications and ACS Synthetic Biology.
